NCT02230995 - Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy

Interventions

DRUG

metformin

single dose of metformin given as tablets

DRUG

empagliflozin/metformin

Single dose empagliflozin/metformin given as fixed-dose combination tablet

DRUG

empagliflozin

single dose of empagliflozin given as tablet

Trial Locations (1)

Boehringer Ingelheim Investigational Site, Biberach an der Riss